Description
Xigduo, a combination oral medication consisting of dapagliflozin and metformin, is utilized in the management of type 2 diabetes. This medication combines the actions of dapagliflozin, a sodium-glucose cotransporter 2 (SGLT2) inhibitor, which helps the kidneys eliminate glucose from the bloodstream, with metformin, which decreases glucose production in the liver and improves the body’s response to insulin.
Reviews
There are no reviews yet.